DIA Biosimilars 2013

Technology Solutions

AstraZeneca selects Dotmatics platform

Monday, July 29, 2013 01:25 PM

AstraZeneca’s Neuroscience Innovative Medicines Unit (iMed) has selected Dotmatics’ cloud based informatics platform as its research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, fully integrated chemistry and biology ELN and project management to enable scientists, collaborators and partners to instantly interact with the same data regardless of location and time zone.

More... »

Cenduit: Now with Patient Reminders

Verified Clinical Trials partners with SAFE-BioPharma

Friday, July 26, 2013 09:00 AM

Verified Clinical Trials, whose technology helps eliminate multiple enrollments by clinical trial volunteers and provides Medicare Secondary Payer Law compliance strategies, will offer its services with SAFE-BioPharma, a global digital identity management and signature standard used by many of the world’s largest biopharmaceutical companies. The company also has joined the SAFE-BioPharma Vendor Partner program, providing it with direct access to decision-makers in SAFE-BioPharma’s member companies.

More... »

CRF Health – eCOA Forum

CROS NT joins DatatrakConnect

Wednesday, July 24, 2013 02:18 PM

Datatrak International, a developer of eClinical technologies, has announced international CRO CROS NT has joined the DatatrakConnect partner program, a collaboration between companies to accelerate the drug development process.

More... »

Healthrageous, United BioSource, Boehringer Ingelheim launch SMART digital diabetes study

Friday, July 19, 2013 01:30 PM

Healthrageous, a digital health management company, and pharmaceutical company Boehringer Ingelheim have launched the SMART study with United BioSource (UBC) to evaluate a digital technology enabled self-management solution to potentially improve the health status of people with type 2 diabetes. The goal of the solution is to leverage technology in a way that makes the personalized journey of self-managing diabetes easier for patients to self-manage their disease.

More... »

Forte launches Overture electronic data capture system

Friday, July 12, 2013 03:14 PM

Forte Research Systems, a developer of clinical research management software, has launched its electronic data capture (EDC) system. Overture EDC is for researchers in the academic setting that need a system to handle complex clinical research protocols.

More... »

FDA, EMA approve C-Path’s simulation tool for Alzheimer’s trials

Friday, July 12, 2013 02:16 PM

Both the FDA and the EMA have independently reached favorable decisions on the value of independent nonprofit Critical Path Institute’s (C-Path) new disease simulation tool for improving trial design in mild and moderate Alzheimer’s disease (AD).

More... »

ERT’s SITEpro Tablet authorized to measure QoL

Friday, July 12, 2013 02:01 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, is authorized to provide validated, electronic versions of commonly used health-related Quality of Life (QoL) questionnaires on SITEpro Tablet—its patient data collection system for use at sites. The questionnaires, developed by professor Elizabeth Juniper, measure QoL among patients in clinical trials of asthma and rhinoconjunctivitis treatments.

More... »

Schrödinger and ChemAxon extend partnership

Thursday, July 11, 2013 09:30 AM

Schrödinger, a drug discovery solutions company, and ChemAxon, a provider of cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries, have extended their partnership agreement for another five years. ChemAxon will provide the JChem chemistry engine as well as Marvin sketching and rendering functionality to Schrödinger's enterprise informatics platform, Seurat.

More... »

Optibrium, AstraZeneca sign deal for global software license

Tuesday, July 9, 2013 11:29 AM

AstraZeneca has signed an agreement to license software developer Optibrium's StarDrop software. StarDrop and the ADME-QSAR and Auto-Modeller modules will be deployed globally to AstraZeneca's researchers.

More... »

IP Shakti launches PipeLinX for open innovation

Wednesday, July 3, 2013 11:30 AM

IP Shakti, an early stage biomedical fund, has launched PipeLinX, a new concept in open innovation solutions. The PipeLinX service sorts through university technology to focus on emerging technologies in the field.

More... »

CenterWatch
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs